Clinical Trial Update: Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with chemoembolization for unresectable liver cancer has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Yale University | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-28